Company: EDSA
Filing Date: 2025-12-12
Form Type: 10-K
Source: 0001171843-25-007914
Chunk: 1162

Company: Edesa Biotech, Inc.
Filing Date: 2025-12-12
Form: 10-K
Item: Item 9
Chunk 1162
---
 holders to purchase common shares of the Company as follows:

			Number of Options

			Weighted Average Exercise Price

			Weighted Average Grant Date Fair Value

			Balance - September 30, 2023

			420,615

			$
			25.60

			$
			18.84

			Granted

			500

			4.10

			3.10

			Forfeited

			(2,401
			)

			15.00

			10.70

			Expired

			(35,674
			)

			33.18

			24.63

			Balance - September 30, 2024

			383,040

			$
			24.93

			$
			18.33

			Forfeited

			(196
			)

			4.10

			3.10

			Expired

			(4,805
			)

			44.18

			37.95

			Balance - September 30, 2025

			378,039

			$
			24.70

			$
			18.12

There were no options exercised during the years ended September 30, 2025 or September 30, 2024. The intrinsic value of options outstanding at September 30, 2025 was $0.00.

The weighted average contractual life remaining on the outstanding options at September 30, 2025 is 68 months.

The following table summarizes information about the options under the 2019 Plan outstanding and exercisable at September 30, 2025:

			Number of Options

			Exercisable at
			September 30, 2025 (#) 

			Range of Exercise Prices 

			Expiry Dates

			37,719

			37,719

			C$
			15.12

			August 2027 - Dec 2028

			43,031

			43,031

			$
			22.12

			Feb 2030

			51,006

			51,006

			$
			52.08 - 56.49

			September 2030 - Oct 2030

			79,651

			79,651